Phosphodiesterase 5 Inhibitor [EPC]

Phosphodiesterase 5 Inhibitor [EPC] was reported 135416 times

Drugs of the Phosphodiesterase 5 Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 125 0.6983
1 DEVICE WIRELESS COMMUNICATION ISSUE 135 0.5212
2 PULMONARY HYPERTENSIVE CRISIS 130 0.4797
3 MALIGNANT MELANOMA STAGE II 75 0.4573
4 DEVICE MAINTENANCE ISSUE 235 0.3997
5 CATHETER SITE PRURITUS 321 0.3656
6 CATHETER MANAGEMENT 324 0.3604
7 MALIGNANT MELANOMA STAGE I 97 0.3566
8 TRANSPLANT EVALUATION 178 0.3504
9 CATHETER SITE RASH 148 0.3274
10 CATHETER SITE VESICLES 63 0.3231
11 WALKING DISTANCE TEST ABNORMAL 120 0.3069
12 PULMONARY ARTERIAL HYPERTENSION 4240 0.2923
13 CATHETER SITE DISCHARGE 321 0.2856
14 CATHETER SITE IRRITATION 95 0.2853
15 INFUSION SITE INFECTION 657 0.2825
16 PULMONARY ARTERIAL PRESSURE INCREASED 446 0.2736
17 PULMONARY VENO-OCCLUSIVE DISEASE 185 0.2643
18 RIGHT VENTRICULAR FAILURE 1820 0.2594
19 INFUSION SITE DISCHARGE 446 0.2541
20 CATHETER SITE ERYTHEMA 544 0.2540
21 PULMONARY ARTERIAL PRESSURE ABNORMAL 69 0.2396
22 LIBIDO DISORDER 311 0.2390
23 MALIGNANT MELANOMA IN SITU 279 0.2252
24 OXYGEN CONSUMPTION INCREASED 530 0.2216
25 VENTILATION PERFUSION MISMATCH 61 0.2171
26 INFUSION SITE WARMTH 257 0.2096
27 INFUSION SITE IRRITATION 267 0.2078
28 INFUSION SITE INDURATION 304 0.2050
29 INFUSION SITE HAEMORRHAGE 661 0.2007
30 INFUSION SITE PAIN 2528 0.1960
31 CATHETER SITE SWELLING 178 0.1902
32 INFUSION SITE VESICLES 98 0.1863
33 INFUSION SITE CELLULITIS 96 0.1818
34 INFUSION SITE ERYTHEMA 1501 0.1779
35 INFUSION SITE INFLAMMATION 125 0.1771
36 INFUSION SITE OEDEMA 147 0.1758
37 CATHETER SITE PAIN 456 0.1756
38 RIGHT VENTRICULAR DILATATION 100 0.1727
39 DEVICE INFUSION ISSUE 418 0.1684
40 CATHETER SITE INFLAMMATION 94 0.1670
41 SPONTANEOUS PENILE ERECTION 103 0.1659
42 INFUSION SITE ABSCESS 81 0.1607
43 PARACENTESIS 98 0.1593
44 INFUSION SITE NODULE 141 0.1467
45 LUNG TRANSPLANT 515 0.1453
46 INFUSION SITE DISCOLOURATION 126 0.1432
47 DEVICE ALARM ISSUE 260 0.1431
48 SYSTEMIC SCLERODERMA 104 0.1429
49 RIGHT VENTRICULAR DYSFUNCTION 155 0.1405
50 INFUSION SITE SWELLING 870 0.1381
51 CATHETER SITE HAEMORRHAGE 340 0.1358
52 CATHETER PLACEMENT 251 0.1352
53 BRAIN NATRIURETIC PEPTIDE INCREASED 416 0.1348
54 BENIGN PROSTATIC HYPERPLASIA 686 0.1327
55 VASCULAR DEVICE INFECTION 600 0.1321
56 PULMONARY HYPERTENSION 2751 0.1319
57 CATHETERISATION CARDIAC 577 0.1300
58 INFUSION SITE DISCOMFORT 133 0.1283
59 SCLERODERMA 464 0.1275
60 INFUSION SITE RASH 169 0.1231
61 CYANOPSIA 72 0.1200
62 INFUSION SITE PRURITUS 366 0.1159
63 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 159 0.1132
64 DIZZINESS EXERTIONAL 86 0.1132
65 PAIN IN JAW 3119 0.1100
66 INFUSION SITE REACTION 323 0.1080
67 CENTRAL VENOUS CATHETERISATION 316 0.1047
68 BLOOD TESTOSTERONE DECREASED 711 0.1038
69 OBSTRUCTIVE SLEEP APNOEA SYNDROME 142 0.0973
70 CATHETER SITE INFECTION 352 0.0930
71 COR PULMONALE 88 0.0921
72 DYSPNOEA AT REST 266 0.0917
73 FLUID OVERLOAD 1335 0.0916
74 HEART TRANSPLANT 81 0.0895
75 THERAPEUTIC RESPONSE INCREASED 84 0.0894
76 DEVICE RELATED SEPSIS 179 0.0888
77 HYPERVOLAEMIA 434 0.0877
78 CATHETER SITE RELATED REACTION 64 0.0853
79 DERMATITIS CONTACT 965 0.0845
80 ASPIRATION PLEURAL CAVITY 65 0.0845
81 MYOGLOBIN BLOOD INCREASED 129 0.0843
82 DYSPNOEA EXERTIONAL 3163 0.0839
83 FLUID RETENTION 4228 0.0830
84 DEVICE RELATED INFECTION 1150 0.0746
85 INFUSION SITE MASS 79 0.0727
86 TRANSFUSION 755 0.0720
87 TELANGIECTASIA 68 0.0705
88 DEVICE CONNECTION ISSUE 146 0.0691
89 OXYGEN THERAPY 112 0.0681
90 CHRONIC RESPIRATORY FAILURE 80 0.0662
91 PRIAPISM 227 0.0658
92 PACKED RED BLOOD CELL TRANSFUSION 86 0.0650
93 HAEMOGLOBIN INCREASED 278 0.0609
94 EJACULATION FAILURE 122 0.0608
95 ECHOCARDIOGRAM ABNORMAL 82 0.0586
96 MALIGNANT MELANOMA 771 0.0575
97 CARDIAC ABLATION 102 0.0570
98 EXERCISE TOLERANCE DECREASED 322 0.0559
99 OXYGEN SATURATION DECREASED 3111 0.0553
100 NOCTURNAL DYSPNOEA 70 0.0549
101 ATRIAL TACHYCARDIA 114 0.0542
102 MECHANICAL VENTILATION 103 0.0542
103 SEASONAL ALLERGY 763 0.0539
104 CARBON DIOXIDE INCREASED 73 0.0535
105 PURULENT DISCHARGE 220 0.0514
106 OPTIC ISCHAEMIC NEUROPATHY 196 0.0506
107 CONCOMITANT DISEASE AGGRAVATED 312 0.0505
108 INJECTION SITE INFECTION 166 0.0505
109 OXYGEN SATURATION ABNORMAL 142 0.0500
110 SUSPECTED COUNTERFEIT PRODUCT 196 0.0495
111 NASAL CONGESTION 2866 0.0487
112 CARDIOVERSION 68 0.0486
113 PENIS DISORDER 118 0.0476
114 THROMBOSIS IN DEVICE 154 0.0469
115 DEVICE POWER SOURCE ISSUE 137 0.0469
116 TRACHEOSTOMY 67 0.0469
117 URINE FLOW DECREASED 112 0.0468
118 ERECTION INCREASED 196 0.0468
119 LEFT VENTRICULAR FAILURE 158 0.0459
120 INFUSION SITE BRUISING 99 0.0458
121 RESPIRATION ABNORMAL 308 0.0446
122 HYPOXIA 1565 0.0444
123 LIVER TRANSPLANT 157 0.0431
124 MIDDLE EAR EFFUSION 92 0.0417
125 ERECTILE DYSFUNCTION 1067 0.0415
126 OEDEMA 2249 0.0414
127 PLANTAR FASCIITIS 139 0.0414
128 SUBSTANCE USE DISORDER 127 0.0398
129 ACUTE RESPIRATORY FAILURE 765 0.0397
130 ORTHOPNOEA 126 0.0395
131 LOCALISED OEDEMA 183 0.0395
132 THERAPY CHANGE 385 0.0391
133 INJECTION SITE DISCHARGE 208 0.0386
134 PULMONARY PAIN 111 0.0380
135 ANORGASMIA 103 0.0379
136 DEVICE OCCLUSION 531 0.0377
137 ATRIAL FLUTTER 301 0.0377
138 DIZZINESS POSTURAL 357 0.0368
139 CONCOMITANT DISEASE PROGRESSION 70 0.0358
140 RHINOVIRUS INFECTION 139 0.0357
141 DRUG TITRATION ERROR 92 0.0356
142 PERICARDIAL EFFUSION 821 0.0355
143 CARDIAC PACEMAKER INSERTION 207 0.0347
144 FLUSHING 3506 0.0345
145 PRODUCT ADMINISTRATION INTERRUPTED 265 0.0337
146 STAPHYLOCOCCUS TEST POSITIVE 69 0.0327
147 DYSLIPIDAEMIA 166 0.0327
148 EAR CONGESTION 88 0.0324
149 METASTATIC MALIGNANT MELANOMA 74 0.0322
150 TRANSPLANT 76 0.0320
151 DEAFNESS UNILATERAL 176 0.0319
152 BLOOD CULTURE POSITIVE 95 0.0317
153 SUDDEN HEARING LOSS 64 0.0316
154 PULMONARY OEDEMA 1397 0.0312
155 PARANASAL SINUS DISCOMFORT 118 0.0311
156 HYPERPARATHYROIDISM SECONDARY 77 0.0307
157 DISEASE COMPLICATION 140 0.0306
158 CARDIAC OPERATION 262 0.0305
159 SINUS CONGESTION 407 0.0301
160 VASODILATATION 75 0.0297
161 SYNCOPE 2969 0.0296
162 FAECES SOFT 215 0.0295
163 BLOOD PRESSURE SYSTOLIC DECREASED 134 0.0294
164 CARDIAC FAILURE ACUTE 195 0.0292
165 ENDOTRACHEAL INTUBATION 82 0.0292
166 DYSPNOEA 16396 0.0289
167 ACTINIC KERATOSIS 74 0.0285
168 BLOOD LOSS ANAEMIA 64 0.0282
169 IRON DEFICIENCY ANAEMIA 259 0.0280
170 COMPLICATION ASSOCIATED WITH DEVICE 407 0.0280
171 CARDIAC FAILURE 2240 0.0279
172 HAEMOPTYSIS 764 0.0274
173 RESPIRATORY SYNCYTIAL VIRUS INFECTION 238 0.0273
174 HAEMATOCRIT INCREASED 62 0.0272
175 NEPHROGENIC ANAEMIA 126 0.0272
176 DRUG TOLERANCE DECREASED 76 0.0270
177 ASCITES 777 0.0264
178 THERAPY NON-RESPONDER 1168 0.0260
179 PRESYNCOPE 624 0.0256
180 OEDEMA PERIPHERAL 3105 0.0254
181 CARDIAC FAILURE CHRONIC 107 0.0251
182 HERNIA REPAIR 64 0.0246
183 EPISTAXIS 1842 0.0246
184 DIALYSIS 349 0.0246
185 PULMONARY CONGESTION 324 0.0246
186 EJACULATION DISORDER 69 0.0243
187 DECREASED ACTIVITY 258 0.0239
188 HYPERCAPNIA 72 0.0239
189 PULMONARY ALVEOLAR HAEMORRHAGE 134 0.0239
190 UPPER RESPIRATORY TRACT CONGESTION 69 0.0238
191 BREATH SOUNDS ABNORMAL 116 0.0235
192 BLOOD IRON DECREASED 279 0.0235
193 SECRETION DISCHARGE 294 0.0235
194 RALES 136 0.0234
195 PRODUCTIVE COUGH 1112 0.0233
196 PARANASAL SINUS HYPERSECRETION 87 0.0228
197 CYANOSIS 358 0.0227
198 PULSELESS ELECTRICAL ACTIVITY 95 0.0227
199 PROSTATITIS 69 0.0227
200 PNEUMONIA VIRAL 72 0.0226
201 DEVICE FAILURE 343 0.0225
202 PORTAL HYPERTENSION 69 0.0224
203 GOUT 401 0.0223
204 SINUS DISORDER 442 0.0223
205 HEADACHE 13856 0.0221
206 CARDIOMEGALY 271 0.0220
207 HYPOTENSION 4404 0.0219
208 NASAL DRYNESS 137 0.0218
209 IDIOPATHIC PULMONARY FIBROSIS 86 0.0217
210 PULMONARY HAEMORRHAGE 170 0.0217
211 RETINAL VEIN OCCLUSION 62 0.0216
212 PNEUMOTHORAX 342 0.0215
213 SINUS HEADACHE 128 0.0215
214 TESTICULAR PAIN 68 0.0214
215 DEVICE DISLOCATION 932 0.0214
216 RESPIRATORY FAILURE 1543 0.0211
217 INFUSION SITE EXTRAVASATION 131 0.0210
218 PENILE PAIN 64 0.0210
219 EAR DISCOMFORT 215 0.0209
220 TENSION HEADACHE 90 0.0209
221 AMMONIA INCREASED 106 0.0208
222 TRICUSPID VALVE INCOMPETENCE 165 0.0207
223 INTERNAL HAEMORRHAGE 236 0.0206
224 COUGH 5747 0.0205
225 RESPIRATORY TRACT CONGESTION 325 0.0204
226 EMERGENCY CARE 62 0.0204
227 DIASTOLIC DYSFUNCTION 63 0.0204
228 PRODUCT LEAKAGE 114 0.0203
229 CARDIAC FAILURE CONGESTIVE 1630 0.0203
230 CHEST PAIN 3751 0.0202
231 OBSTRUCTIVE AIRWAYS DISORDER 224 0.0201
232 CHOKING SENSATION 111 0.0201
233 STENT PLACEMENT 162 0.0201
234 INCORRECT DRUG ADMINISTRATION RATE 85 0.0200
235 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 123 0.0199
236 BODY HEIGHT DECREASED 212 0.0198
237 AORTIC STENOSIS 69 0.0198
238 CARDIAC FLUTTER 128 0.0198
239 PERIPHERAL SWELLING 3021 0.0196
240 PROSTATOMEGALY 77 0.0196
241 VIRAL UPPER RESPIRATORY TRACT INFECTION 93 0.0195
242 PALPITATIONS 2280 0.0194
243 BLOOD CHOLESTEROL INCREASED 907 0.0194
244 BLOOD PRESSURE DECREASED 1288 0.0194
245 IRON DEFICIENCY 87 0.0193
246 THROAT IRRITATION 867 0.0193
247 CARDIOPULMONARY FAILURE 75 0.0192
248 SENSATION OF FOREIGN BODY 161 0.0191
249 CHEST DISCOMFORT 1890 0.0184
250 PNEUMONIA 5955 0.0184
251 SUPRAVENTRICULAR TACHYCARDIA 175 0.0183
252 BACTERAEMIA 216 0.0182
253 INCREASED UPPER AIRWAY SECRETION 93 0.0181
254 HAEMORRHOIDAL HAEMORRHAGE 88 0.0180
255 BLOOD POTASSIUM DECREASED 540 0.0179
256 UNEVALUABLE EVENT 1348 0.0178
257 WEIGHT FLUCTUATION 186 0.0178
258 HEART RATE ABNORMAL 99 0.0177
259 HEAD DISCOMFORT 312 0.0176
260 POLYURIA 144 0.0176
261 TERMINAL STATE 117 0.0175
262 ATRIAL FIBRILLATION 1701 0.0174
263 CLOSTRIDIUM DIFFICILE INFECTION 381 0.0174
264 HEPATIC CIRRHOSIS 327 0.0174
265 GASTROENTERITIS VIRAL 314 0.0174
266 LUNG DISORDER 846 0.0172
267 PLEURAL EFFUSION 1040 0.0171
268 CHEMOTHERAPY 64 0.0169
269 STAPHYLOCOCCAL BACTERAEMIA 73 0.0168
270 VIRAL INFECTION 558 0.0168
271 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 874 0.0167
272 CARDIOGENIC SHOCK 240 0.0167
273 SUBARACHNOID HAEMORRHAGE 167 0.0164
274 LOCALISED INFECTION 396 0.0164
275 GENERALISED OEDEMA 200 0.0161
276 HAEMODYNAMIC INSTABILITY 123 0.0161
277 MYALGIA 2732 0.0161
278 INTERNATIONAL NORMALISED RATIO DECREASED 65 0.0160
279 RESPIRATORY DISTRESS 443 0.0160
280 DIARRHOEA 10353 0.0160
281 SLEEP APNOEA SYNDROME 306 0.0160
282 PREMATURE DELIVERY 253 0.0159
283 HOSPICE CARE 156 0.0158
284 HEART RATE INCREASED 1554 0.0157
285 DEAFNESS 407 0.0155
286 BLOOD PRESSURE ABNORMAL 309 0.0155
287 SPUTUM DISCOLOURED 147 0.0155
288 HOT FLUSH 1168 0.0155
289 LARGE INTESTINE POLYP 107 0.0154
290 FACIAL PAIN 137 0.0153
291 UPPER-AIRWAY COUGH SYNDROME 126 0.0153
292 CARDIAC DISORDER 1428 0.0152
293 CELLULITIS 764 0.0151
294 CARDIAC TAMPONADE 72 0.0151
295 MULTIPLE ALLERGIES 118 0.0150
296 URINE OUTPUT DECREASED 131 0.0150
297 DEVICE PHYSICAL PROPERTY ISSUE 114 0.0149
298 PERFORMANCE STATUS DECREASED 69 0.0148
299 PAIN IN EXTREMITY 4340 0.0147
300 THERAPEUTIC RESPONSE DECREASED 892 0.0147
301 HOSPITALISATION 2258 0.0147
302 UPPER RESPIRATORY TRACT INFECTION 679 0.0147
303 EXOSTOSIS 134 0.0147
304 GASTROOESOPHAGEAL REFLUX DISEASE 1181 0.0147
305 HEAD INJURY 460 0.0145
306 DYSPEPSIA 1421 0.0144
307 END STAGE RENAL DISEASE 261 0.0143
308 SWELLING 1336 0.0143
309 SUDDEN DEATH 151 0.0143
310 MICTURITION URGENCY 163 0.0143
311 DIZZINESS 7112 0.0142
312 ABDOMINAL DISTENSION 1476 0.0141
313 SLUGGISHNESS 144 0.0141
314 BACK PAIN 3277 0.0141
315 NASOPHARYNGITIS 2594 0.0141
316 TINNITUS 644 0.0140
317 VISUAL FIELD DEFECT 101 0.0140
318 THERAPY CESSATION 713 0.0139
319 RHINORRHOEA 894 0.0138
320 DEVICE LEAKAGE 599 0.0138
321 SKIN ABRASION 65 0.0137
322 SARCOIDOSIS 65 0.0137
323 BRONCHITIS 1008 0.0136
324 RETCHING 290 0.0136
325 PULMONARY THROMBOSIS 148 0.0136
326 PULMONARY FIBROSIS 260 0.0135
327 LUNG INFECTION 206 0.0132
328 HAEMATOCRIT DECREASED 260 0.0131
329 INFLUENZA 1455 0.0130
330 FLANK PAIN 122 0.0130
331 MUSCULOSKELETAL CHEST PAIN 200 0.0129
332 FOOD POISONING 69 0.0129
333 TROPONIN INCREASED 98 0.0129
334 ULCER HAEMORRHAGE 87 0.0128
335 POLLAKIURIA 529 0.0127
336 SKIN INFECTION 142 0.0126
337 HEART RATE IRREGULAR 286 0.0126
338 ACUTE PULMONARY OEDEMA 71 0.0126
339 PNEUMONIA BACTERIAL 116 0.0126
340 RESPIRATORY TRACT INFECTION 329 0.0126
341 CORONARY ARTERY DISEASE 382 0.0126
342 LOSS OF CONSCIOUSNESS 1614 0.0126
343 CARDIAC VALVE DISEASE 72 0.0126
344 RESPIRATORY DISORDER 376 0.0126
345 RETINAL DETACHMENT 115 0.0125
346 BRONCHIECTASIS 84 0.0125
347 QUALITY OF LIFE DECREASED 167 0.0124
348 EYE HAEMORRHAGE 166 0.0124
349 VISUAL DISTURBANCE 71 0.0124
350 NASAL DISCOMFORT 98 0.0123
351 OROPHARYNGEAL PAIN 1137 0.0123
352 NOCTURIA 149 0.0123
353 STAPHYLOCOCCAL INFECTION 403 0.0122
354 BLOOD COUNT ABNORMAL 185 0.0122
355 VARICOSE VEIN 63 0.0122
356 MEDICAL DEVICE COMPLICATION 90 0.0122
357 INTENTIONAL DOSE OMISSION 347 0.0122
358 EAR INFECTION 323 0.0121
359 WHEEZING 712 0.0120
360 TRISMUS 62 0.0120
361 GASTROINTESTINAL HAEMORRHAGE 1002 0.0120
362 NO THERAPEUTIC RESPONSE 146 0.0120
363 ENDOCARDITIS 61 0.0119
364 ANAEMIA 2265 0.0119
365 FAECES DISCOLOURED 257 0.0118
366 VISION BLURRED 1627 0.0118
367 RESTLESS LEGS SYNDROME 215 0.0118
368 ABDOMINAL DISCOMFORT 1980 0.0118
369 MUSCLE STRAIN 102 0.0118
370 ANAL INCONTINENCE 106 0.0118
371 HEPATIC ENCEPHALOPATHY 109 0.0117
372 BRAIN FOG 183 0.0117
373 THERAPY INTERRUPTED 834 0.0117
374 SUBDURAL HAEMATOMA 167 0.0117
375 PREMATURE BABY 351 0.0116
376 TREATMENT NONCOMPLIANCE 637 0.0116
377 THERAPY PARTIAL RESPONDER 181 0.0116
378 ATELECTASIS 112 0.0116
379 HAEMOGLOBIN DECREASED 1189 0.0116
380 LOSS OF LIBIDO 104 0.0116
381 DEPRESSED MOOD 611 0.0115
382 NECK PAIN 644 0.0115
383 OROPHARYNGEAL DISCOMFORT 104 0.0115
384 ASTHENIA 4311 0.0115
385 SEPSIS 1272 0.0114
386 MALAISE 4983 0.0114
387 PRODUCT DOSE OMISSION 741 0.0113
388 FEELING COLD 316 0.0113
389 MOUTH HAEMORRHAGE 83 0.0113
390 PELVIC FRACTURE 88 0.0113
391 BOWEL MOVEMENT IRREGULARITY 86 0.0112
392 RENAL DISORDER 522 0.0112
393 NAUSEA 8855 0.0112
394 VENTRICULAR TACHYCARDIA 184 0.0111
395 RIB FRACTURE 228 0.0111
396 PHOTOPSIA 70 0.0111
397 HIP FRACTURE 356 0.0111
398 SQUAMOUS CELL CARCINOMA 104 0.0110
399 MIGRAINE 1054 0.0110
400 WEIGHT DECREASED 3082 0.0110
401 SKIN LACERATION 120 0.0110
402 ELECTROLYTE IMBALANCE 128 0.0110
403 CONDITION AGGRAVATED 3345 0.0110
404 CARDIAC ARREST 905 0.0110
405 DISEASE PROGRESSION 1297 0.0110
406 COVID-19 PNEUMONIA 129 0.0109
407 MUSCULOSKELETAL DISCOMFORT 188 0.0109
408 DECREASED APPETITE 2513 0.0108
409 FEELING ABNORMAL 2586 0.0108
410 PERIORBITAL SWELLING 61 0.0108
411 CATARACT OPERATION 64 0.0108
412 BLINDNESS UNILATERAL 152 0.0108
413 CIRCULATORY COLLAPSE 183 0.0107
414 LIGAMENT SPRAIN 106 0.0107
415 HAEMORRHOIDS 209 0.0107
416 HAEMATEMESIS 270 0.0106
417 TRANSIENT ISCHAEMIC ATTACK 359 0.0106
418 GASTROENTERITIS 155 0.0106
419 LIMB INJURY 288 0.0106
420 HEPATOMEGALY 104 0.0106
421 BLINDNESS TRANSIENT 78 0.0106
422 FATIGUE 8234 0.0106
423 RENAL FAILURE 1399 0.0105
424 HYPOACUSIS 453 0.0105
425 DYSPHONIA 615 0.0105
426 VOMITING 4923 0.0105
427 DEHYDRATION 1394 0.0104
428 OCULAR DISCOMFORT 117 0.0104
429 CHOLECYSTECTOMY 119 0.0104
430 MUSCULOSKELETAL PAIN 544 0.0104
431 CLOSTRIDIUM DIFFICILE COLITIS 110 0.0104
432 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 63 0.0103
433 CHRONIC KIDNEY DISEASE 784 0.0103
434 PROCEDURAL COMPLICATION 79 0.0103
435 MENTAL STATUS CHANGES 286 0.0103
436 RHINITIS 83 0.0103
437 DIABETES MELLITUS 782 0.0102
438 BASAL CELL CARCINOMA 160 0.0102
439 SINUSITIS 1051 0.0102
440 BLOOD BILIRUBIN INCREASED 277 0.0102
441 SMALL INTESTINAL OBSTRUCTION 126 0.0102
442 POLYP 67 0.0102
443 BLOOD ALKALINE PHOSPHATASE INCREASED 254 0.0102
444 PRODUCT SUPPLY ISSUE 73 0.0102
445 LACERATION 96 0.0102
446 INTERSTITIAL LUNG DISEASE 494 0.0102
447 HEART RATE DECREASED 358 0.0102
448 LOW BIRTH WEIGHT BABY 81 0.0102
449 SLEEP DISORDER 716 0.0101
450 TACHYCARDIA 898 0.0101
451 BLOOD MAGNESIUM DECREASED 87 0.0101
452 DEATH 8680 0.0101
453 FLATULENCE 569 0.0100
454 GASTRIC HAEMORRHAGE 115 0.0100
455 LIMB DISCOMFORT 309 0.0100
456 EAR PAIN 194 0.0100
457 WEIGHT INCREASED 2229 0.0099
458 KIDNEY INFECTION 195 0.0099
459 HERNIA 192 0.0099
460 DRY THROAT 100 0.0098
461 ABNORMAL LOSS OF WEIGHT 67 0.0098
462 BACTERIAL INFECTION 183 0.0098
463 JOINT INJURY 209 0.0098
464 TOOTHACHE 177 0.0098
465 VISUAL IMPAIRMENT 1211 0.0098
466 SNEEZING 219 0.0098
467 BACK INJURY 106 0.0097
468 FULL BLOOD COUNT ABNORMAL 103 0.0097
469 HYPERTENSION 2062 0.0097
470 TACHYPNOEA 132 0.0097
471 GALLBLADDER DISORDER 173 0.0097
472 UNINTENTIONAL MEDICAL DEVICE REMOVAL 112 0.0097
473 GASTRIC DISORDER 332 0.0097
474 ATRIAL SEPTAL DEFECT 81 0.0097
475 BLOOD POTASSIUM INCREASED 157 0.0097
476 BEDRIDDEN 127 0.0097
477 APPETITE DISORDER 64 0.0096
478 PHOTOPHOBIA 181 0.0096
479 EMPHYSEMA 97 0.0096
480 GASTROINTESTINAL DISORDER 860 0.0096
481 FALL 3195 0.0096
482 GROIN PAIN 84 0.0096
483 ABDOMINAL PAIN UPPER 1969 0.0096
484 NEURALGIA 232 0.0095
485 POOR QUALITY SLEEP 205 0.0095
486 BLOOD PRESSURE DIASTOLIC DECREASED 70 0.0095
487 POST PROCEDURAL COMPLICATION 182 0.0095
488 LOWER GASTROINTESTINAL HAEMORRHAGE 70 0.0095
489 HIP ARTHROPLASTY 145 0.0095
490 PALLOR 257 0.0094
491 INTERNATIONAL NORMALISED RATIO INCREASED 269 0.0094
492 FEELING HOT 578 0.0094
493 NEPHROPATHY 88 0.0094
494 UPPER GASTROINTESTINAL HAEMORRHAGE 158 0.0094
495 HYPERSOMNIA 268 0.0093
496 SCIATICA 149 0.0093
497 BRONCHOSPASM 133 0.0093
498 ASPIRATION 102 0.0093
499 PROSTATIC SPECIFIC ANTIGEN INCREASED 128 0.0093
500 MUSCLE SPASMS 1693 0.0092
501 LIVER FUNCTION TEST INCREASED 197 0.0092
502 CHILLS 1073 0.0091
503 DIVERTICULUM 65 0.0091
504 OCULAR HYPERAEMIA 434 0.0091
505 BLOOD UREA INCREASED 153 0.0091
506 BLOOD SODIUM DECREASED 172 0.0091
507 CEREBRAL HAEMORRHAGE 326 0.0091
508 UNRESPONSIVE TO STIMULI 235 0.0091
509 GINGIVAL BLEEDING 124 0.0091
510 EOSINOPHILIA 159 0.0091
511 SKIN ULCER 234 0.0090
512 HYPERTHYROIDISM 131 0.0090
513 CONCUSSION 70 0.0090
514 FREQUENT BOWEL MOVEMENTS 244 0.0090
515 PERIPHERAL COLDNESS 124 0.0090
516 TOOTH INFECTION 119 0.0090
517 DIPLOPIA 234 0.0090
518 HYSTERECTOMY 78 0.0090
519 ARRHYTHMIA 426 0.0090
520 CARDIO-RESPIRATORY ARREST 376 0.0090
521 RECTAL HAEMORRHAGE 386 0.0090
522 MELAENA 197 0.0089
523 SWELLING FACE 579 0.0089
524 SYSTEMIC LUPUS ERYTHEMATOSUS 315 0.0089
525 VITREOUS FLOATERS 87 0.0088
526 ORTHOSTATIC HYPOTENSION 154 0.0088
527 DEVICE ISSUE 792 0.0088
528 LETHARGY 508 0.0088
529 SPINAL COMPRESSION FRACTURE 73 0.0088
530 HIATUS HERNIA 114 0.0088
531 ERUCTATION 170 0.0088
532 POST PROCEDURAL HAEMORRHAGE 102 0.0088
533 DYSURIA 321 0.0087
534 DIVERTICULITIS 240 0.0087
535 PULMONARY MASS 129 0.0087
536 PNEUMONIA ASPIRATION 216 0.0086
537 LACRIMATION INCREASED 261 0.0086
538 UPPER LIMB FRACTURE 172 0.0086
539 ISCHAEMIC STROKE 154 0.0086
540 DRUG DOSE OMISSION 1423 0.0086
541 ANKLE FRACTURE 133 0.0086
542 IMPAIRED GASTRIC EMPTYING 117 0.0086
543 HYPOKALAEMIA 396 0.0086
544 RED BLOOD CELL COUNT DECREASED 245 0.0086
545 BLINDNESS 349 0.0086
546 VENTRICULAR FIBRILLATION 95 0.0085
547 ANGINA PECTORIS 245 0.0085
548 TOOTH ABSCESS 87 0.0085
549 DRUG INTOLERANCE 823 0.0085
550 PHARYNGITIS STREPTOCOCCAL 92 0.0085
551 ASPARTATE AMINOTRANSFERASE INCREASED 451 0.0085
552 GASTROINTESTINAL INFECTION 76 0.0085
553 EYE SWELLING 315 0.0085
554 LIVER FUNCTION TEST ABNORMAL 246 0.0085
555 ACUTE KIDNEY INJURY 1289 0.0084
556 ELECTROCARDIOGRAM ABNORMAL 66 0.0084
557 AORTIC ANEURYSM 64 0.0084
558 SARS-COV-2 TEST POSITIVE 111 0.0084
559 SURGERY 491 0.0084
560 INTENTIONAL PRODUCT MISUSE 733 0.0084
561 KNEE OPERATION 82 0.0083
562 HAEMATOCHEZIA 458 0.0083
563 DEVICE USE ERROR 288 0.0083
564 PYREXIA 2855 0.0082
565 EYE INFECTION 93 0.0082
566 RENAL IMPAIRMENT 688 0.0082
567 VISUAL ACUITY REDUCED 272 0.0082
568 BACK DISORDER 133 0.0082
569 BLOOD CREATININE INCREASED 533 0.0082
570 SEPTIC SHOCK 355 0.0082
571 LUNG INFILTRATION 72 0.0081
572 URINARY TRACT INFECTION 1389 0.0081
573 CHOLECYSTITIS 97 0.0081
574 MULTIPLE ORGAN DYSFUNCTION SYNDROME 230 0.0081
575 AUTOIMMUNE DISORDER 79 0.0081
576 COLON CANCER 120 0.0080
577 BLOOD PRESSURE FLUCTUATION 193 0.0080
578 TOOTH EXTRACTION 100 0.0080
579 MUSCLE TIGHTNESS 130 0.0080
580 SEXUAL DYSFUNCTION 94 0.0080
581 HAEMORRHAGE 838 0.0080
582 ACUTE MYOCARDIAL INFARCTION 236 0.0080
583 THROMBOSIS 642 0.0080
584 HYPERCHOLESTEROLAEMIA 77 0.0080
585 LIVER DISORDER 351 0.0079
586 INSOMNIA 2108 0.0079
587 SPLENOMEGALY 92 0.0078
588 ILLNESS 808 0.0078
589 RENAL PAIN 83 0.0078
590 APPENDICITIS 73 0.0078
591 SPINAL OPERATION 96 0.0078
592 ROAD TRAFFIC ACCIDENT 326 0.0078
593 ECONOMIC PROBLEM 118 0.0078
594 INJECTION SITE IRRITATION 99 0.0078
595 RESPIRATORY RATE INCREASED 69 0.0078
596 INFECTION 1122 0.0077
597 APHONIA 108 0.0077
598 ASPHYXIA 63 0.0077
599 SCAB 88 0.0077
600 INITIAL INSOMNIA 79 0.0077
601 MALNUTRITION 86 0.0077
602 JOINT SWELLING 918 0.0076
603 ANOSMIA 109 0.0075
604 GENERAL PHYSICAL HEALTH DETERIORATION 868 0.0075
605 ABDOMINAL PAIN 1744 0.0075
606 ANHEDONIA 197 0.0075
607 COLD SWEAT 132 0.0075
608 SPINAL FRACTURE 150 0.0075
609 MACULAR DEGENERATION 89 0.0074
610 BLOOD URINE PRESENT 141 0.0074
611 LIP SWELLING 247 0.0074
612 ARTHRALGIA 3083 0.0074
613 CHOLELITHIASIS 243 0.0074
614 PAIN 4512 0.0073
615 MITRAL VALVE INCOMPETENCE 83 0.0073
616 PRODUCT DISTRIBUTION ISSUE 68 0.0073
617 COVID-19 1281 0.0073
618 BRAIN INJURY 73 0.0073
619 VITAMIN D DECREASED 62 0.0072
620 BLADDER DISORDER 72 0.0072
621 ALANINE AMINOTRANSFERASE INCREASED 445 0.0072
622 OESOPHAGITIS 79 0.0072
623 CORONARY ARTERY OCCLUSION 99 0.0072
624 INTESTINAL OBSTRUCTION 272 0.0072
625 DEVICE MALFUNCTION 507 0.0072
626 TASTE DISORDER 146 0.0072
627 DRY MOUTH 583 0.0072
628 CARDIAC MURMUR 62 0.0072
629 UROSEPSIS 66 0.0071
630 CONSTIPATION 1558 0.0071
631 CATARACT 425 0.0071
632 CHOKING 139 0.0071
633 PLATELET COUNT DECREASED 759 0.0071
634 FEELING JITTERY 135 0.0071
635 LOWER LIMB FRACTURE 136 0.0071
636 ARTHRITIS 556 0.0071
637 INFLUENZA LIKE ILLNESS 581 0.0071
638 ACCIDENTAL OVERDOSE 258 0.0070
639 ULCER 112 0.0070
640 ORAL CANDIDIASIS 92 0.0070
641 EYE PAIN 394 0.0070
642 INTRAOCULAR PRESSURE INCREASED 89 0.0070
643 ABSCESS 111 0.0070
644 PHARYNGITIS 86 0.0069
645 DEVICE BREAKAGE 281 0.0069
646 GLOMERULAR FILTRATION RATE DECREASED 85 0.0069
647 ANXIETY 1967 0.0069
648 GLAUCOMA 133 0.0069
649 NIGHT SWEATS 222 0.0069
650 MUSCULAR WEAKNESS 783 0.0069
651 VASCULITIS 80 0.0069
652 CHROMATURIA 155 0.0069
653 GAMMA-GLUTAMYLTRANSFERASE INCREASED 152 0.0069
654 FEEDING DISORDER 139 0.0068
655 GASTRITIS 180 0.0068
656 EYE DISORDER 224 0.0068
657 MYOCARDIAL ISCHAEMIA 77 0.0068
658 INSURANCE ISSUE 103 0.0067
659 INTERVERTEBRAL DISC DEGENERATION 62 0.0067
660 FACE OEDEMA 113 0.0067
661 ROTATOR CUFF SYNDROME 86 0.0067
662 BLOOD TEST ABNORMAL 94 0.0067
663 ACUTE RESPIRATORY DISTRESS SYNDROME 117 0.0066
664 HYPERLIPIDAEMIA 79 0.0066
665 NERVE COMPRESSION 61 0.0066
666 KNEE ARTHROPLASTY 139 0.0066
667 WRIST FRACTURE 79 0.0066
668 BODY TEMPERATURE INCREASED 134 0.0066
669 PRODUCT USE ISSUE 1233 0.0066
670 DRUG INTERACTION 1038 0.0065
671 ACCIDENT 78 0.0065
672 TEMPERATURE INTOLERANCE 67 0.0065
673 FOOT FRACTURE 123 0.0065
674 BONE PAIN 379 0.0065
675 SCRATCH 68 0.0064
676 VERTIGO 390 0.0064
677 MUSCLE ATROPHY 81 0.0064
678 THIRST 114 0.0064
679 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 452 0.0063
680 PETECHIAE 66 0.0063
681 CYSTITIS 201 0.0063
682 WOUND 176 0.0063
683 RASH PRURITIC 341 0.0063
684 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 302 0.0063
685 OSTEOPENIA 95 0.0063
686 SKIN DISCOLOURATION 287 0.0062
687 EXTRA DOSE ADMINISTERED 252 0.0062
688 HAEMORRHAGE INTRACRANIAL 93 0.0062
689 DEPRESSION 1415 0.0062
690 BRADYCARDIA 329 0.0062
691 HEPATIC FAILURE 187 0.0062
692 SOMNOLENCE 1248 0.0062
693 HYPERHIDROSIS 798 0.0062
694 HYPERBILIRUBINAEMIA 64 0.0062
695 HERPES ZOSTER 355 0.0062
696 NEPHROLITHIASIS 283 0.0062
697 CONTUSION 593 0.0062
698 OSTEOMYELITIS 111 0.0061
699 CAESAREAN SECTION 71 0.0061
700 THYROID DISORDER 94 0.0061
701 ERYTHEMA 1248 0.0061
702 GAIT DISTURBANCE 1161 0.0061
703 MEMORY IMPAIRMENT 833 0.0061
704 HAEMATOMA 157 0.0061
705 AGEUSIA 151 0.0060
706 BALANCE DISORDER 522 0.0060
707 BLOOD PRESSURE INCREASED 921 0.0060
708 EYELID OEDEMA 70 0.0060
709 DEVICE USE ISSUE 105 0.0060
710 CANDIDA INFECTION 101 0.0060
711 PULMONARY EMBOLISM 568 0.0060
712 PERICARDITIS 100 0.0059
713 GAIT INABILITY 197 0.0059
714 LYMPHADENOPATHY 208 0.0059
715 THROAT TIGHTNESS 158 0.0058
716 COMA 278 0.0058
717 LABORATORY TEST ABNORMAL 172 0.0058
718 BREAST PAIN 62 0.0058
719 RESPIRATORY ARREST 160 0.0058
720 PRODUCT SUBSTITUTION ISSUE 334 0.0058
721 NERVOUSNESS 303 0.0058
722 HEPATIC STEATOSIS 108 0.0058
723 HEMIPARESIS 98 0.0058
724 MIDDLE INSOMNIA 106 0.0057
725 AMNESIA 367 0.0056
726 URINARY INCONTINENCE 167 0.0056
727 ILEUS 70 0.0056
728 HEPATIC FUNCTION ABNORMAL 210 0.0056
729 MOOD ALTERED 153 0.0056
730 COAGULOPATHY 93 0.0056
731 GASTRIC ULCER 106 0.0056
732 DRUG INEFFECTIVE 7337 0.0056
733 GENERALISED TONIC-CLONIC SEIZURE 92 0.0056
734 HYPOPHAGIA 142 0.0055
735 GASTROINTESTINAL PAIN 61 0.0055
736 CONFUSIONAL STATE 894 0.0055
737 URINARY RETENTION 184 0.0055
738 DYSSTASIA 161 0.0055
739 LUNG NEOPLASM MALIGNANT 226 0.0055
740 MYOCARDIAL INFARCTION 959 0.0055
741 TUBULOINTERSTITIAL NEPHRITIS 103 0.0055
742 DISCOMFORT 335 0.0055
743 PANCREATITIS 288 0.0054
744 CARPAL TUNNEL SYNDROME 76 0.0054
745 SINUS TACHYCARDIA 77 0.0054
746 WHITE BLOOD CELL COUNT INCREASED 208 0.0054
747 PRODUCT DOSE OMISSION IN ERROR 153 0.0054
748 LOCAL SWELLING 94 0.0054
749 SCAR 92 0.0054
750 CEREBROVASCULAR ACCIDENT 907 0.0053
751 RASH MACULAR 187 0.0053
752 CARDIOMYOPATHY 79 0.0053
753 JAUNDICE 143 0.0053
754 HYPOAESTHESIA 795 0.0053
755 EXPOSURE DURING PREGNANCY 330 0.0053
756 PRODUCT DOSE OMISSION ISSUE 1554 0.0053
757 LOWER RESPIRATORY TRACT INFECTION 240 0.0053
758 DRUG ABUSE 439 0.0053
759 TREMOR 874 0.0053
760 FULL BLOOD COUNT DECREASED 106 0.0053
761 RENAL INJURY 156 0.0052
762 ORAL PAIN 117 0.0052
763 HYPERKALAEMIA 183 0.0052
764 TOOTH DISORDER 116 0.0052
765 OFF LABEL USE 4561 0.0052
766 COLITIS 197 0.0052
767 INJECTION SITE INDURATION 67 0.0052
768 PANIC ATTACK 188 0.0052
769 DEMENTIA 144 0.0051
770 OBESITY 82 0.0051
771 ADVERSE EVENT 474 0.0051
772 PRODUCT USE COMPLAINT 81 0.0051
773 SKIN DISORDER 170 0.0051
774 EYE PRURITUS 171 0.0051
775 HAEMATURIA 174 0.0051
776 PARAESTHESIA 795 0.0050
777 SHOCK 116 0.0050
778 DYSPHAGIA 478 0.0050
779 PANCREATITIS ACUTE 113 0.0050
780 HYPOGLYCAEMIA 242 0.0050
781 OSTEOPOROSIS 204 0.0050
782 FUNGAL INFECTION 165 0.0049
783 INTERVERTEBRAL DISC PROTRUSION 108 0.0049
784 APATHY 72 0.0049
785 SKIN IRRITATION 226 0.0049
786 NEOPLASM MALIGNANT 327 0.0049
787 BURNING SENSATION 343 0.0049
788 HYPONATRAEMIA 274 0.0049
789 DERMATITIS ALLERGIC 61 0.0048
790 MUSCLE TWITCHING 111 0.0048
791 BLISTER 269 0.0048
792 INTENTIONAL PRODUCT USE ISSUE 418 0.0048
793 NEUROPATHY PERIPHERAL 453 0.0048
794 IRRITABLE BOWEL SYNDROME 102 0.0048
795 HYPERSENSITIVITY 874 0.0047
796 PARANOIA 81 0.0047
797 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 952 0.0047
798 IMPAIRED QUALITY OF LIFE 67 0.0047
799 DELIRIUM 161 0.0046
800 EXPIRED PRODUCT ADMINISTERED 154 0.0046
801 SENSORY DISTURBANCE 74 0.0046
802 PRODUCT ADMINISTRATION ERROR 93 0.0046
803 ENCEPHALOPATHY 113 0.0046
804 RASH 1993 0.0046
805 OSTEOARTHRITIS 193 0.0045
806 RESTLESSNESS 166 0.0045
807 RASH ERYTHEMATOUS 216 0.0045
808 BLOOD PRESSURE SYSTOLIC INCREASED 88 0.0045
809 MULTI-ORGAN FAILURE 78 0.0045
810 MASS 63 0.0045
811 APHASIA 136 0.0045
812 PRESCRIBED OVERDOSE 87 0.0045
813 PREGNANCY 90 0.0045
814 MENORRHAGIA 88 0.0045
815 PHOTOSENSITIVITY REACTION 74 0.0045
816 BLOOD GLUCOSE DECREASED 215 0.0045
817 BLOOD GLUCOSE ABNORMAL 82 0.0044
818 C-REACTIVE PROTEIN INCREASED 161 0.0044
819 SEIZURE 511 0.0044
820 DISORIENTATION 175 0.0044
821 ANGIOEDEMA 195 0.0044
822 DRUG-INDUCED LIVER INJURY 138 0.0044
823 HYPOAESTHESIA ORAL 66 0.0044
824 CARDIOVASCULAR DISORDER 111 0.0044
825 EATING DISORDER 93 0.0044
826 LEUKOCYTOSIS 79 0.0044
827 HYPOKINESIA 63 0.0043
828 TENDONITIS 67 0.0043
829 DISTURBANCE IN ATTENTION 233 0.0043
830 PARAESTHESIA ORAL 62 0.0043
831 DYSGEUSIA 319 0.0043
832 MOBILITY DECREASED 308 0.0043
833 MUSCULOSKELETAL STIFFNESS 372 0.0042
834 INTENTIONAL OVERDOSE 272 0.0042
835 WRONG TECHNIQUE IN DRUG USAGE PROCESS 154 0.0042
836 METABOLIC ACIDOSIS 135 0.0042
837 MENTAL IMPAIRMENT 102 0.0042
838 AGITATION 309 0.0042
839 ASTHMA 475 0.0042
840 APPLICATION SITE PRURITUS 95 0.0042
841 INFLAMMATION 216 0.0042
842 ADVERSE DRUG REACTION 375 0.0042
843 DEVICE ADHESION ISSUE 64 0.0042
844 INTENTIONAL DRUG MISUSE 87 0.0042
845 JOINT STIFFNESS 109 0.0042
846 DRY EYE 207 0.0041
847 THROMBOCYTOPENIA 463 0.0041
848 PROSTATE CANCER 333 0.0041
849 INCREASED APPETITE 79 0.0041
850 PANCYTOPENIA 230 0.0041
851 SPEECH DISORDER 215 0.0041
852 CONJUNCTIVITIS 76 0.0041
853 PRURITUS 1569 0.0041
854 FEMUR FRACTURE 126 0.0041
855 TRANSAMINASES INCREASED 90 0.0040
856 DRUG ERUPTION 71 0.0040
857 COGNITIVE DISORDER 187 0.0040
858 DRUG LEVEL INCREASED 66 0.0040
859 FOETAL EXPOSURE DURING PREGNANCY 323 0.0040
860 SWOLLEN TONGUE 124 0.0040
861 ABDOMINAL PAIN LOWER 100 0.0040
862 CEREBRAL INFARCTION 96 0.0039
863 MENTAL DISORDER 170 0.0039
864 PAIN OF SKIN 104 0.0039
865 PNEUMONITIS 105 0.0039
866 EYE IRRITATION 219 0.0038
867 DEEP VEIN THROMBOSIS 247 0.0038
868 DYSARTHRIA 143 0.0038
869 ILL-DEFINED DISORDER 230 0.0038
870 DIABETES MELLITUS INADEQUATE CONTROL 67 0.0038
871 MEDICATION ERROR 210 0.0038
872 FRACTURE 71 0.0037
873 IRRITABILITY 225 0.0037
874 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 264 0.0037
875 RASH PAPULAR 83 0.0037
876 LIVER INJURY 90 0.0037
877 PRURITUS GENERALISED 79 0.0036
878 HEPATIC ENZYME INCREASED 249 0.0036
879 INJECTION SITE RASH 112 0.0036
880 INCORRECT DOSE ADMINISTERED 830 0.0036
881 MATERNAL EXPOSURE DURING PREGNANCY 321 0.0036
882 CHOLESTASIS 69 0.0036
883 BLOOD CREATINE PHOSPHOKINASE INCREASED 102 0.0035
884 INJECTION SITE ERYTHEMA 439 0.0035
885 HYPOTHYROIDISM 112 0.0035
886 IMPAIRED HEALING 115 0.0035
887 SKIN CANCER 75 0.0035
888 FIBROMYALGIA 84 0.0035
889 RHABDOMYOLYSIS 144 0.0034
890 SKIN LESION 94 0.0034
891 GYNAECOMASTIA 106 0.0034
892 PROCEDURAL PAIN 95 0.0034
893 THERAPEUTIC RESPONSE UNEXPECTED 153 0.0034
894 HALLUCINATION 256 0.0034
895 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 186 0.0034
896 THINKING ABNORMAL 63 0.0034
897 ALTERED STATE OF CONSCIOUSNESS 73 0.0034
898 MOVEMENT DISORDER 108 0.0034
899 UNDERDOSE 245 0.0034
900 GLYCOSYLATED HAEMOGLOBIN INCREASED 84 0.0033
901 RASH GENERALISED 86 0.0033
902 CONTRAINDICATED PRODUCT ADMINISTERED 100 0.0033
903 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 594 0.0033
904 WHITE BLOOD CELL COUNT DECREASED 355 0.0033
905 ANGER 110 0.0032
906 RENAL FAILURE ACUTE 138 0.0032
907 URTICARIA 544 0.0032
908 INJECTION SITE PRURITUS 217 0.0032
909 MOOD SWINGS 102 0.0032
910 TOXICITY TO VARIOUS AGENTS 539 0.0032
911 VAGINAL HAEMORRHAGE 138 0.0032
912 PRODUCT AVAILABILITY ISSUE 72 0.0032
913 ABNORMAL DREAMS 87 0.0031
914 NIGHTMARE 108 0.0031
915 ABASIA 77 0.0031
916 HYPERGLYCAEMIA 112 0.0031
917 CRYING 111 0.0031
918 BONE DENSITY DECREASED 95 0.0030
919 ARTHROPATHY 168 0.0030
920 PRODUCT PRESCRIBING ISSUE 65 0.0030
921 INJECTION SITE HAEMORRHAGE 236 0.0030
922 EMOTIONAL DISORDER 91 0.0029
923 DEPRESSED LEVEL OF CONSCIOUSNESS 116 0.0029
924 EPILEPSY 89 0.0029
925 GLOSSODYNIA 65 0.0029
926 FEAR 78 0.0029
927 AGGRESSION 144 0.0029
928 INJECTION SITE SWELLING 220 0.0029
929 EMOTIONAL DISTRESS 345 0.0028
930 DRY SKIN 380 0.0028
931 THERAPEUTIC PRODUCT EFFECT DECREASED 127 0.0028
932 DYSKINESIA 115 0.0028
933 TYPE 2 DIABETES MELLITUS 95 0.0028
934 OVERDOSE 605 0.0028
935 INCORRECT DOSE ADMINISTERED BY DEVICE 72 0.0027
936 DRUG ADMINISTRATION ERROR 83 0.0027
937 BLOOD GLUCOSE INCREASED 507 0.0027
938 ABNORMAL BEHAVIOUR 105 0.0026
939 COMPLETED SUICIDE 219 0.0026
940 SUICIDAL IDEATION 240 0.0026
941 PSORIATIC ARTHROPATHY 106 0.0026
942 APPLICATION SITE ERYTHEMA 68 0.0026
943 ECZEMA 133 0.0025
944 DIABETIC KETOACIDOSIS 61 0.0025
945 SKIN EXFOLIATION 204 0.0024
946 DRUG EFFECT DECREASED 130 0.0024
947 PLASMA CELL MYELOMA 94 0.0024
948 EXPOSURE VIA SKIN CONTACT 62 0.0024
949 DISEASE RECURRENCE 113 0.0024
950 INJURY 164 0.0023
951 INJECTION SITE PAIN 714 0.0023
952 STOMATITIS 138 0.0023
953 ELECTROCARDIOGRAM QT PROLONGED 81 0.0022
954 DRUG EFFECT INCOMPLETE 81 0.0022
955 PANCREATIC CARCINOMA 64 0.0022
956 ANAPHYLACTIC REACTION 121 0.0022
957 PRODUCT USE IN UNAPPROVED INDICATION 542 0.0022
958 DEVICE DIFFICULT TO USE 144 0.0022
959 COLITIS ULCERATIVE 97 0.0022
960 PSYCHOTIC DISORDER 63 0.0021
961 OSTEONECROSIS 70 0.0021
962 CONVULSION 115 0.0020
963 TREATMENT FAILURE 166 0.0020
964 ALOPECIA 392 0.0020
965 NERVOUS SYSTEM DISORDER 61 0.0020
966 PSORIASIS 237 0.0018
967 INJECTION SITE MASS 65 0.0018
968 RHEUMATOID ARTHRITIS 198 0.0017
969 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 81 0.0017
970 BLADDER CANCER 100 0.0017
971 INFUSION RELATED REACTION 112 0.0017
972 WITHDRAWAL SYNDROME 70 0.0017
973 LEUKOPENIA 81 0.0016
974 BREAST CANCER 149 0.0016
975 SUICIDE ATTEMPT 95 0.0016
976 INJECTION SITE BRUISING 120 0.0015
977 ACNE 113 0.0015
978 MULTIPLE SCLEROSIS 70 0.0015
979 PRODUCT QUALITY ISSUE 197 0.0014
980 INJECTION SITE REACTION 99 0.0014
981 NEUTROPENIA 188 0.0014
982 NO ADVERSE EVENT 242 0.0013
983 FEBRILE NEUTROPENIA 87 0.0013
984 ACCIDENTAL EXPOSURE TO PRODUCT 135 0.0013
985 DERMATITIS ATOPIC 69 0.0013
986 SKIN BURNING SENSATION 92 0.0013
987 MULTIPLE SCLEROSIS RELAPSE 84 0.0012
988 DRUG WITHDRAWAL SYNDROME 96 0.0011
989 MALIGNANT NEOPLASM PROGRESSION 84 0.0008
990 DRUG DEPENDENCE 115 0.0007